Back to Search
LEA FAYAD, MD
MD
Gastroenterology Physician
NPI: 1316501851IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
ME175002(FL)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 2017
Research & Publications (20)
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT.
PMID 19029968·Bone Marrow Transplant·2009
5-case
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
PMID 19150940·Ann Oncol·2009
8-other
Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma.
PMID 19593328·Mod Pathol·2009
4-observational
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results.
PMID 19451441·J Clin Oncol·2009
3-trial
Functional joint imaging using 256-MDCT: Technical feasibility.
PMID 19457792·AJR Am J Roentgenol·2009
8-other
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
PMID 18085611·Cancer·2008
3-trial
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
PMID 18764869·Br J Haematol·2008
3-trial
[High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
PMID 18221676·Med Clin (Barc)·2008
4-observational
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
PMID 18411419·Blood·2008
3-trial
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
PMID 18223284·Haematologica·2008
3-trial
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.
PMID 18779406·Blood·2008
8-other
Symptomatic anterior sternoclavicular joint secondary to a bicipital rib.
PMID 18926199·J Pediatr Surg·2008
5-case
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
PMID 18182663·J Clin Oncol·2008
3-trial
Anterior cruciate ligament volume: analysis of gender differences.
PMID 18050351·J Magn Reson Imaging·2008
8-other
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
PMID 18083690·Ann Oncol·2008
8-other
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
PMID 18973182·Cancer·2008
3-trial
Low-grade intramedullary osteosarcoma of the tibia presenting as an intracortical lesion.
PMID 19292367·Orthopedics·2008
5-case
Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures.
PMID 18581111·Skeletal Radiol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 NW 12TH AVE
MIAMI, FL 33136 - Phone
- (305) 689-5413
Quick Facts
- NPI
- 1316501851
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile